Dang, Bich N.
Graham, David Y.
Article History
First Online: 3 May 2017
Competing interests
: D.Y.G. is a consultant for RedHill Biopharma regarding novel H. pylori therapies and has received research support for culture of H. pylori and is the principal investigator of an international study of the use of antimycobacterial therapy for Crohn's disease. He is also a consultant for BioGaia in relation to probiotic therapy for H. pylori infection and for Takeda in relation to H. pylori therapies. B.N.D. declares no competing interests.